These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Binding of osteopontin to the osteoclast integrin alpha v beta 3. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh D. Osteoporos Int; 1993 Feb; 3 Suppl 1():132-5. PubMed ID: 8461540 [Abstract] [Full Text] [Related]
51. Recognition of cryptic sites in human and mouse laminins by rat osteoclasts is mediated by beta 3 and beta 1 integrins. Horton MA, Spragg JH, Bodary SC, Helfrich MH. Bone; 1994 Feb; 15(6):639-46. PubMed ID: 7532981 [Abstract] [Full Text] [Related]
52. Integrin expression and adhesion property of osteoclast-like cells from giant cell tumours of bone. Grano M, Colucci S, Zigrino P, Serra M, Scotlandi K, Teti A, Zambonin Zallone A. Boll Soc Ital Biol Sper; 1992 Apr; 68(4):255-8. PubMed ID: 1463599 [Abstract] [Full Text] [Related]
53. Echistatin is a potent inhibitor of bone resorption in culture. Sato M, Sardana MK, Grasser WA, Garsky VM, Murray JM, Gould RJ. J Cell Biol; 1990 Oct; 111(4):1713-23. PubMed ID: 2211834 [Abstract] [Full Text] [Related]
54. Inhibition of osteoclastic bone resorption in vivo by echistatin, an "arginyl-glycyl-aspartyl" (RGD)-containing protein. Fisher JE, Caulfield MP, Sato M, Quartuccio HA, Gould RJ, Garsky VM, Rodan GA, Rosenblatt M. Endocrinology; 1993 Mar; 132(3):1411-3. PubMed ID: 8440195 [Abstract] [Full Text] [Related]
55. Localization and possible role of two different alpha v beta 3 integrin conformations in resting and resorbing osteoclasts. Faccio R, Grano M, Colucci S, Villa A, Giannelli G, Quaranta V, Zallone A. J Cell Sci; 2002 Jul 15; 115(Pt 14):2919-29. PubMed ID: 12082152 [Abstract] [Full Text] [Related]
56. A peptidomimetic antagonist of the alpha(v)beta3 integrin inhibits bone resorption in vitro and prevents osteoporosis in vivo. Engleman VW, Nickols GA, Ross FP, Horton MA, Griggs DW, Settle SL, Ruminski PG, Teitelbaum SL. J Clin Invest; 1997 May 01; 99(9):2284-92. PubMed ID: 9151803 [Abstract] [Full Text] [Related]
57. Synthesis and solution conformation of cyclo[RGDRGD]: a cyclic peptide with selectivity for the alpha V beta 3 receptor. Burgess K, Lim D, Mousa SA. J Med Chem; 1996 Oct 25; 39(22):4520-6. PubMed ID: 8893849 [Abstract] [Full Text] [Related]
58. Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. Miyauchi A, Alvarez J, Greenfield EM, Teti A, Grano M, Colucci S, Zambonin-Zallone A, Ross FP, Teitelbaum SL, Cheresh D. J Biol Chem; 1991 Oct 25; 266(30):20369-74. PubMed ID: 1939092 [Abstract] [Full Text] [Related]
59. Ca2+ suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin alpha v beta 3. Hu DD, Hoyer JR, Smith JW. J Biol Chem; 1995 Apr 28; 270(17):9917-25. PubMed ID: 7537271 [Abstract] [Full Text] [Related]
60. Mammalian oocytes exhibit specific recognition of the RGD (Arg-Gly-Asp) tripeptide and express oolemmal integrins. Fusi FM, Vignali M, Gailit J, Bronson RA. Mol Reprod Dev; 1993 Oct 28; 36(2):212-9. PubMed ID: 8257570 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]